Aspen Pharmacare Holdings Limited

Research Aspen Pharmacare Holdings Limited (LDZA) on Bullrun: market cap EUR 3.36B, dividend yield 1.3%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 3.36B; dividend yield is 1.3%.

Peer valuation comparison

Latest dividend yield is 1.31% versus a Healthcare sector median of 2.11% (37.9% below).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025ZAR 43.36B-ZAR 1.08BZAR 104.00M44.1%-2.44ZAR 6.41BZAR 36.12BZAR 84.89B
FY2024ZAR 44.71BZAR 4.40BZAR 690.00M43.5%9.91ZAR 12.34BZAR 36.46BZAR 84.86B
FY2023ZAR 40.71BZAR 5.23BZAR 2.34B45.2%11.77ZAR 10.91BZAR 29.28BZAR 86.24B
FY2022ZAR 38.61BZAR 6.49BZAR 2.68B47.4%14.32ZAR 6.18BZAR 22.25BZAR 70.94B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-23EUR 3.36Bn/a1.4%0.1

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.1 EUR, yield 1.3%.

YearDividends/share
FY20250.11 ZAR
FY20240.19 ZAR
FY20230.18 ZAR
FY20220.17 ZAR
FY20210.14 ZAR

About Aspen Pharmacare Holdings Limited

Aspen Pharmacare Holdings Limited, together with its subsidiaries, operates as a specialty and branded pharmaceutical company in Africa, the Middle East, Europe, CIS, Australasia, Asia, and the Americas. It operates through Commercial Pharmaceuticals and Manufacturing segments.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Aspen Pharmacare Holdings Limited's market cap?

Aspen Pharmacare Holdings Limited's market capitalization is EUR 3.36B.

Does Aspen Pharmacare Holdings Limited pay a dividend?

Aspen Pharmacare Holdings Limited has a dividend yield of 1.3%.

What does Aspen Pharmacare Holdings Limited do?

Aspen Pharmacare Holdings Limited, together with its subsidiaries, operates as a specialty and branded pharmaceutical company in Africa, the Middle East, Europe, CIS, Australasia, Asia, and the Americas. It operates through Commercial Pharmaceuticals and Manufacturing segments.